{"api":"v1","generated_at":"2026-10-01T10:18:32.155Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-nafcs-9cb2a8","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-nafcs-9cb2a8/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-nafcs-9cb2a8","canonical_url":"https://api.magentlab.com/api/calc/nafcs","resource":"https://api.magentlab.com/api/calc/nafcs","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG >880 mg/dL or >10 mmol/L, TG/TC >8 (mg/dL) or >3.5 (mmol/L), and apo B <1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.","service_name":"magent","declared_category":null,"declared_tags":["nafcs","fcs","lipids","chylomicronemia","hegele-2025"],"route_template":null,"registry_updated":"2026-09-28T14:20:24.983Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc nafcs","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:20:24.860Z"},"validation":{"latest":{"observed_at":"2026-10-01T08:40:57.181Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T08:40:57.181Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:04:28.838Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:15:42.090Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T17:21:33.440Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:45:56.713Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["nafcs","fcs","lipids","chylomicronemia","hegele-2025"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/nafcs","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:20:24.86Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/nafcs","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"tg_mg_dl":500,"age_years":40,"apo_b_g_l":1.2,"tg_mmol_l":8,"apo_b_mg_dl":120,"abdominal_history":"none","tg_tc_ratio_mg_dl":5,"tg_tc_ratio_mmol_l":2,"bmi_below_threshold":false,"htg_onset_before_age_10":false,"secondary_factors_present":true},{"tg_mg_dl":500,"age_years":40,"apo_b_g_l":1.2,"tg_mmol_l":8,"apo_b_mg_dl":120,"abdominal_history":"none","tg_tc_ratio_mg_dl":5,"tg_tc_ratio_mmol_l":2,"bmi_below_threshold":false,"htg_onset_before_age_10":false,"secondary_factors_present":true}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/nafcs","count":2,"items":[{"score":0,"formula":"nafcs","citation":{"id":"hegele-2025","doi":"10.1016/j.jacl.2024.09.008","pmid":"39537503","title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","source":"J Clin Lipidol. 2025;19(1):83-94","authors":"Hegele RA, Ahmad Z, Ashraf A, et al."},"age_years":40,"low_apo_b":false,"max_score":100,"components":[{"factor":"early_htg_onset","points":0,"present":false},{"factor":"child_htg","points":0,"present":false},{"factor":"all_tg_severely_elevated","points":0,"present":false},{"factor":"high_tg_tc_ratio","points":0,"present":false},{"factor":"low_apo_b","points":0,"present":false},{"factor":"bmi_below_threshold","points":0,"present":false},{"factor":"abdominal_pain","points":0,"present":false},{"factor":"pancreatitis","points":0,"present":false},{"factor":"no_secondary_factors","points":0,"present":false},{"factor":"high_ratio_and_low_apo_b","points":0,"present":false},{"factor":"child_and_no_secondary","points":0,"present":false},{"factor":"high_ratio_and_no_secondary","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","high_tg_tc_ratio":false,"formula_expression":"NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS","definite_classical_fcs":false,"all_tg_severely_elevated":false,"very_likely_classical_fcs":false},{"score":0,"formula":"nafcs","citation":{"id":"hegele-2025","doi":"10.1016/j.jacl.2024.09.008","pmid":"39537503","title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","source":"J Clin Lipidol. 2025;19(1):83-94","authors":"Hegele RA, Ahmad Z, Ashraf A, et al."},"age_years":40,"low_apo_b":false,"max_score":100,"components":[{"factor":"early_htg_onset","points":0,"present":false},{"factor":"child_htg","points":0,"present":false},{"factor":"all_tg_severely_elevated","points":0,"present":false},{"factor":"high_tg_tc_ratio","points":0,"present":false},{"factor":"low_apo_b","points":0,"present":false},{"factor":"bmi_below_threshold","points":0,"present":false},{"factor":"abdominal_pain","points":0,"present":false},{"factor":"pancreatitis","points":0,"present":false},{"factor":"no_secondary_factors","points":0,"present":false},{"factor":"high_ratio_and_low_apo_b","points":0,"present":false},{"factor":"child_and_no_secondary","points":0,"present":false},{"factor":"high_ratio_and_no_secondary","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","high_tg_tc_ratio":false,"formula_expression":"NAFCS = early_htg_onset 12 (age_years ≥10 and htg_onset_before_age_10) + child_htg 12 (age_years 1-9) + all_tg_severely_elevated 13 (all fasting TG >880 mg/dL or >10 mmol/L) + high_tg_tc_ratio 8 (TG/TC >8 mg/dL or >3.5 mmol/L) + low_apo_b 12 (apo B <1.0 g/L or <100 mg/dL) + bmi_below_threshold 9 (BMI <25 kg/m2 or <85th percentile) + abdominal_pain 9 (recurrent abdominal pain without pancreatitis) + pancreatitis 16 + no_secondary_factors 11 + high_ratio_and_low_apo_b 7 + child_and_no_secondary 7 + high_ratio_and_no_secondary 5 (Hegele 2025 Table 3, parameter estimates ×10); max 100; ≥60 definite classical FCS; ≥45 very likely classical FCS","definite_classical_fcs":false,"all_tg_severely_elevated":false,"very_likely_classical_fcs":false}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age_years","htg_onset_before_age_10","bmi_below_threshold","abdominal_history","secondary_factors_present"],"properties":{"tg_mg_dl":{"type":"number","description":"Caller-assigned fasting triglycerides in mg/dL (440-20000) representing all readings used in the score (Hegele 2025 Table 1: last 3 labs in adults, last 2 in children). All readings >880 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids."},"age_years":{"type":"integer","description":"Current age in whole years (1-120). Hegele 2025 Table 3: ages 1-9 score child_htg 12; ages ≥10 score early_htg_onset 12 only when htg_onset_before_age_10 is true. The score does not provide a value for infants <1 year. magent does not examine the patient."},"apo_b_g_l":{"type":"number","description":"Apolipoprotein B in g/L (0.1-3.0). <1.0 scores 12 (Hegele 2025 Table 3). Provide exactly one of apo_b_g_l or apo_b_mg_dl. 1.0 g/L = 100 mg/dL in the paper. magent does not assay apo B."},"tg_mmol_l":{"type":"number","description":"Caller-assigned fasting triglycerides in mmol/L (5-226). All readings >10 score 13. Provide exactly one of tg_mg_dl or tg_mmol_l. magent does not assay lipids."},"apo_b_mg_dl":{"type":"number","description":"Apolipoprotein B in mg/dL (10-300). <100 scores 12. Provide exactly one of apo_b_g_l or apo_b_mg_dl. magent does not assay apo B."},"abdominal_history":{"enum":["none","abdominal_pain","pancreatitis"],"type":"string","description":"Caller-assigned chylomicronemia-related abdominal history (Hegele 2025 Table 3): none (0), abdominal_pain = recurrent abdominal pain without pancreatitis (9), pancreatitis = history of pancreatitis with or without abdominal pain (16). magent does not diagnose pancreatitis."},"tg_tc_ratio_mg_dl":{"type":"number","description":"Triglyceride/total-cholesterol ratio when both are in mg/dL (0.1-80). >8 scores 8 (Hegele 2025 Table 1). Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids."},"tg_tc_ratio_mmol_l":{"type":"number","description":"Triglyceride/total-cholesterol ratio when both are in mmol/L (0.1-35). >3.5 scores 8. Provide exactly one of tg_tc_ratio_mg_dl or tg_tc_ratio_mmol_l. magent does not assay lipids."},"bmi_below_threshold":{"type":"boolean","description":"BMI <25.0 kg/m2 in adults or <85th percentile in children/adolescents as assigned by the caller (Hegele 2025 Table 3, 9 points). true or false. magent does not compute BMI or pediatric percentiles."},"htg_onset_before_age_10":{"type":"boolean","description":"Hypertriglyceridemia onset in infancy or childhood (before age 10) as assigned by the caller (Hegele 2025 Table 1). true or false. Scores 12 only when age_years ≥10. For ages 1-9, child_htg is scored from age and this flag does not add points. magent does not date onset."},"secondary_factors_present":{"type":"boolean","description":"One or more secondary factors that may contribute to hypertriglyceridemia as assigned by the caller (Hegele 2025 Table 1: lifestyle, medications, clinical conditions). true (≥1, 0 points) or false (none, 11 points, plus published interactions). magent does not take a history."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG >880 mg/dL or >10 mmol/L, TG/TC >8 (mg/dL) or >3.5 (mmol/L), and apo B <1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.","lastUpdated":"2026-09-28T14:20:24.983Z","serviceName":"magent","x402Version":2}]}}